- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
4 result(s) found for: Capillary Permeability.
Displaying page 1 of 1.
EudraCT Number: 2017-003855-47 | Sponsor Protocol Number: AP301-II-002 | Start Date*: 2018-02-27 | ||||||||||||||||
Sponsor Name:Apeptico Forschung und Entwicklung GmbH | ||||||||||||||||||
Full Title: Safety and preliminary efficacy of sequential multiple ascending doses of solnatide to treat pulmonary permeability oedema in patients with moderate-to-severe ARDS - a randomised, placebo-controlle... | ||||||||||||||||||
Medical condition: pulmonary permeability oedema in patients with moderate-to-severe ARDS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Ongoing) DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001244-26 | Sponsor Protocol Number: COV-2-SOLNATIDE-20 | Start Date*: 2020-04-11 | ||||||||||||||||
Sponsor Name:Department of Clinical Pharmacology, Medical University of Vienna, Vienna Austria | ||||||||||||||||||
Full Title: COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial. | ||||||||||||||||||
Medical condition: Pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003056-21 | Sponsor Protocol Number: WIRE | Start Date*: 2020-02-07 | ||||||||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge | ||||||||||||||||||
Full Title: Window-of-opportunity clinical trials platform for evaluation of novel treatment strategies in renal cell cancer. | ||||||||||||||||||
Medical condition: Surgically resectable renal cell cancer (Stage M0/M1) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002056-20 | Sponsor Protocol Number: APHP200495 | Start Date*: 2020-10-14 |
Sponsor Name:Assistance Publique -Hôpitaux de Paris | ||
Full Title: FX06 to rescue acute respiratory distress syndrome during Covid-19 pneumonia : FX-COVID | ||
Medical condition: Patients admitted in participating ICUs who received mechanical ventilation for SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.